Insider Trading April 13, 2026 08:36 AM

Clearwater Analytics CTO Sells $240,120 in Stock as Company Nears 52-Week High

Souvik Das executed a planned sale of 10,000 Class A shares; Clearwater remains subject to acquisition and recent analyst downgrades

By Jordan Park CWAN
Clearwater Analytics CTO Sells $240,120 in Stock as Company Nears 52-Week High
CWAN

Clearwater Analytics Holdings Inc. Chief Technology Officer Souvik Das sold 10,000 shares of Class A common stock on April 8, 2026, in a transaction that generated $240,120. The sale was carried out under a pre-arranged Rule 10b5-1 plan and comes as the stock trades near its 52-week high. The company is navigating an announced acquisition and has recently seen multiple analyst rating changes and a new client win in Europe.

Key Points

  • CTO Souvik Das sold 10,000 Class A shares on April 8, 2026, for $240,120 under a pre-arranged Rule 10b5-1 plan.
  • Clearwater is trading near a 52-week high and is the subject of an agreed acquisition by a consortium led by Permira and Warburg Pincus, supported by Francisco Partners and Temasek.
  • Following the acquisition announcement, several sell-side firms downgraded the stock or adjusted ratings, and Generali Deutschland AG awarded Clearwater a €40 billion mandate.

Overview

Clearwater Analytics Holdings Inc. (NYSE: CWAN) reported an insider sale by Chief Technology Officer Souvik Das on April 8, 2026. A Form 4 filing with the Securities and Exchange Commission shows Das sold 10,000 shares of Class A common stock at a weighted average price of $24.012 per share. Individual sale prices reported in the filing ranged from $23.99 to $24.05, producing a total transaction value of $240,120.

Post-transaction holdings and market context

Following the disposition, Das directly holds 200,109 shares of Clearwater Analytics. At the time of the filing the company has an enterprise value cited at $7.1 billion and its share price was trading close to a 52-week high of $25.07 after a 35% gain over the preceding six months. The filing notes the sale was executed pursuant to a Rule 10b5-1 trading plan that Das adopted on May 6, 2025. The Form 4 was signed on his behalf by Alphonse Valbrune, acting as Attorney-in-Fact.

Near-term financial calendar

Clearwater Analytics is scheduled to report earnings on May 6, 2026.

Company performance and strategic developments

In its most recent quarter, Clearwater Analytics reported fourth-quarter results that slightly exceeded both the company’s internal forecasts and external analyst expectations. The company did not host a conference call or issue financial guidance for 2026, a choice the filing links to the company’s pending sale process. Clearwater has entered into an agreement to be acquired by a consortium led by Permira and Warburg Pincus, with support from Francisco Partners and Temasek.

Analyst responses after acquisition news

Following the acquisition announcement several sell-side firms adjusted their ratings and price targets. RBC Capital downgraded the stock to Sector Perform from Outperform, citing the merger proxy as a factor, and set a price target of $24.55. Morgan Stanley downgraded its rating from Overweight to Equalweight, and UBS moved from Buy to Neutral; both Morgan Stanley and UBS set a price target of $24.55.

New client engagement

Separately, Generali Deutschland AG selected Clearwater Analytics to manage its €40 billion unit-linked fund life insurance business, a mandate intended to consolidate the insurer’s portfolio management processes.

Valuation reference and profitability outlook

At the time of the filing, Clearwater was trading above its InvestingPro Fair Value, a position that places it among stocks characterized as overvalued. The article notes that analysts nonetheless expect net income growth for the company in the current year.


Summary of the transaction

  • Insider: Souvik Das, Chief Technology Officer
  • Shares sold: 10,000 Class A common shares
  • Date of sale: April 8, 2026
  • Weighted average price: $24.012; price range $23.99 to $24.05
  • Total transaction value: $240,120
  • Post-sale direct ownership: 200,109 shares
  • Sale executed under a Rule 10b5-1 plan adopted May 6, 2025; Form 4 signed by Alphonse Valbrune as Attorney-in-Fact

Contextual takeaways

  • The stock is trading near its 52-week high of $25.07 after a 35% rise over six months.
  • Clearwater is in the process of being acquired by a consortium led by Permira and Warburg Pincus, with support from Francisco Partners and Temasek.
  • Recent quarterly results slightly beat expectations, but management withheld guidance and did not host a conference call because of the pending buyout.
  • Major financial institutions adjusted their ratings to reflect the changed corporate outlook and transaction dynamics, commonly setting a $24.55 price target.
  • Generali Deutschland AG selected Clearwater to manage a €40 billion unit-linked insurance fund, expanding Clearwater’s client footprint.

Risks

  • Uncertainty tied to the pending acquisition - the company did not provide 2026 guidance or host an earnings call because of the buyout process, which may limit near-term visibility for investors.
  • Analyst rating adjustments - multiple firms lowered their ratings or shifted to neutral/sector perform, reflecting changes in market expectations tied to the merger proxy and potentially compressing near-term share performance.
  • Valuation considerations - trading above InvestingPro Fair Value places the stock among overvalued names, even as analysts expect net income growth, creating evaluation risk for investors.

More from Insider Trading

Japan Post Trims Stake in Aflac with $9.76M Share Sale Apr 13, 2026 Mastech Digital 10% Holder Adds 6,000 Shares in Two-Day Buying Spree Apr 13, 2026 Insider Jorey Chernett Adds $62,000 in Oncology Institute Stock Apr 13, 2026 CoreWeave CSO Venturo Disposes $5.51 Million in Class A Shares Under 10b5-1 Plan Apr 10, 2026 CoreWeave COO Sells Shares as Company Signs Major AI and Cloud Deals, Prices Convertible Notes Apr 10, 2026